Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 9/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | JAK1 | P23458 | 1/20 | 0.39 |
| ▸ | TYK2 | P29597 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4920485 | 0.93 | CHRM3 (0.46) | CHRM3ATMLMNANTRK1TDP1 | |
| SCHEMBL29445383 | 0.89 | CHRM3 (0.51) | CHRM3LMNA | |
| SCHEMBL29437140 | 0.89 | CHRM3 (0.42) | CHRM3LMNAIRAK4 | |
| SCHEMBL304334 | 0.89 | CHRM3 (0.42) | CHRM3LMNAIRAK4 | |
| SCHEMBL29349968 | 0.89 | CHRM3 (0.51) | CHRM3LMNA | |
| SCHEMBL68043 | 0.89 | CHRM3 (0.51) | CHRM3LMNA | |
| SCHEMBL29419144 | 0.89 | TDP1 (0.53) | CHRM3ATMLMNANTRK1TDP1 | |
| SCHEMBL121957 | 0.89 | TDP1 (0.53) | CHRM3ATMLMNANTRK1TDP1 | |
| SCHEMBL302468 | 0.88 | JAK2 (0.48) | CHRM3ATMLMNATDP1KDM4E | |
| SCHEMBL374079 | 0.88 | ATM (0.43) | CHRM3ATMLMNANTRK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2437595-A2 | USE OF SUCCINATE DEHYDROGENASE INHIBITORS FOR CONTROLLING SCLEROTINIA SSP | Bayer CropScience AG (DE) | 2012-04-11 | — | — | EP | claimed |
| US-20120035165-A1 | Use of fungicidal compound compositions for controlling certain rust fungi | BAYER CROPSCIENCE AG (DE) | 2012-02-09 | — | — | US | claimed |
| EP-2330905-A1 | USE OF FUNGICIDAL COMPOUND COMPOSITIONS FOR CONTROLLING CERTAIN RUST FUNGI | Bayer CropScience AG (DE) | 2011-06-15 | — | — | EP | claimed |
| US-20110105331-A1 | Method of Plant Growth Promotion Using Amide Compounds | BAYER CROPSCIENCE AG (DE) | 2011-05-05 | — | — | US | claimed |
| US-20110003869-A1 | Use of Succinate Dehydrogenase Inhibitors for Controlling Sclerotinia ssp. | BAYER CROPSCIENCE AG (DE) | 2011-01-06 | — | — | US | claimed |
| EP-2268145-A1 | METHOD OF PLANT GROWTH PROMOTION USING AMIDE COMPOUNDS | Bayer CropScience AG (DE) | 2011-01-05 | — | — | EP | claimed |
| WO-2010139410-A2 | USE OF SUCCINATE DEHYDROGENASE INHIBITORS FOR CONTROLLING SCLEROTINIA SSP. | BAYER CROPSCIENCE AG (DE) | 2010-12-09 | — | — | WO | claimed |
| WO-2010025832-A1 | USE OF FUNGICIDAL COMPOUND COMPOSITIONS FOR CONTROLLING CERTAIN RUST FUNGI | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | WO | claimed |
| WO-2009118161-A1 | METHOD OF PLANT GROWTH PROMOTION USING AMIDE COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-10-01 | — | — | WO | claimed |
| EP-2105049-A1 | Method of plant growth promotion using amide compounds | Bayer CropScience AG (DE) | 2009-09-30 | — | — | EP | claimed |
| US-9877482-B2 | Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-9414600-B2 | Active compound combinations | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-08-16 | — | — | US | disclosed |
| US-20160205932-A1 | Use of Succinate Dehydrogenase Inhibitors for Controlling Sclerotinia ssp. | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-07-21 | — | — | US | disclosed |
| US-9232794-B2 | Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-01-12 | — | — | US | disclosed |
| US-8754009-B2 | Active compound combinations | BAYER CROPSCIENCE AG (DE) | 2014-06-17 | — | — | US | disclosed |
| EP-2001299-A2 | FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS | Bayer CropScience Aktiengesellschaft (DE) | 2008-12-17 | — | — | EP | disclosed |
| US-20080108686-A1 | N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | disclosed |
| US-20080108686-A1 | N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | disclosed |
| US-20080108686-A1 | N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | disclosed |
| WO-2007110173-A2 | FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108686-A1 | N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides | CBR3, DDT, CBR1 | CHRM3 34/4885ATM 3853/4885LMNA 3047/4885 |
| US-20110105331-A1 | Method of Plant Growth Promotion Using Amide Compounds | MYB, GHITM, MKI67 | CHRM3 4166/4885ATM 3205/4885LMNA 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.